Stock Titanยท48 event signal
No transactions reported by Spero Therapeutics (SPRO) director William Ho.
Spero Therapeutics Inc.'s recent Form 3 filing identifies William Ho as a new director, reporting zero transactions. The filing, accepted by the SEC on November 10, 2026, also includes a director power-of-attorney exhibit. This indicates that while Mr. Ho has joined the board, he has not yet engaged in any beneficial ownership activities of company securities.
Put this headline into context
Use TradingAgents AI to connect the story to the company's filings, fundamentals, market structure, competing bull and bear arguments, and risk review.
Source: Alpha VantageRead at Stock Titan
Headlines and excerpts belong to the original publisher. Ticker associations are informational and may be incomplete. Market news is not personalized financial advice.